BIVDA is delighted that Genedrive’s genetic test has been officially recommended for use in NICE’s final guidance. The assessment of the test was carried out carried out through NICE’s Early Value Assessment pilot project, which aims to enable earlier access to digital products, medical devices and diagnostics that address national unmet needs in health and social care. We hope to see many more…
Natalie CreaneyApril 6, 2023